Proficio Capital Partners’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-233
Closed -$31K 1821
2019
Q2
$31K Sell
233
-33
-12% -$4.25K 0.01% 531
2019
Q1
$36K Buy
266
+140
+111% +$17.4K 0.01% 452
2018
Q4
$12K Sell
126
-125
-50% -$14.8K 0.01% 702
2018
Q3
$35K Hold
251
0.01% 435
2018
Q2
$31K Buy
251
+20
+9% +$2.34K 0.01% 477
2018
Q1
$26K Sell
231
-51
-18% -$6.1K 0.01% 521
2017
Q4
$34K Sell
282
-18
-6% -$2.19K 0.01% 444
2017
Q3
$42K Buy
300
+8
+3% +$1.09K 0.02% 425
2017
Q2
$40K Buy
292
+115
+65% +$13.4K 0.02% 439
2017
Q1
$18K Buy
177
+14
+9% +$1.8K 0.01% 655
2016
Q4
$20K Buy
163
+128
+366% +$15.7K 0.01% 450
2016
Q3
$4K Buy
35
+11
+46% +$1.42K ﹤0.01% 784
2016
Q2
$3K Buy
24
+23
+2,300% +$3.26K ﹤0.01% 802
2016
Q1
$0 Sell
1
-45
-98% -$6.61K ﹤0.01% 1205
2015
Q4
$9K Buy
+46
New +$8.04K 0.01% 298

Other funds holding ALXN